Alnylam Pharmaceuticals, Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Alnylam Pharmaceuticals with three other
companies in this sector in the United States:
Integrated Biopharma, Inc.
sales of $42.21 million
of which 100%
was Cancer Therapeutics), and
China Yct International Group, Inc.
During the year ended December of 2016, sales at
Alnylam Pharmaceuticals were $47.16 million.
increase of 14.8%
versus 2015, when the company's sales were $41.10 million.
Despite this increase, sales are still
below the level achieved in 2014, when Alnylam Pharmaceuticals
reported sales of $50.56 million.